EUVIMEDObjevte EUVIMED
Video/Audio

Identification of Hub Genes, Single-Nucleotide Polymorphisms, and Potential Drug Targets In Breast Cancer Using Transcriptomic Analysis

Xiaobo Jia, Hui Su, Jiaxin Zhang, Zhao Liu

Journal of Visualized Experiments · 2026

DOI: 10.3791/70964 ↗

At a glance

Video/Audio in Journal of Visualized Experiments, 2026. Written by Xiaobo Jia and 3 co-authors. Institution: Department of Thyroid and Breast Surgery, The Affiliated Hospital of Xuzhou Medical University; x98013112@gmail.com. Major MEDLINE topics: Breast Neoplasms, Gene Expression Profiling. 58 references.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

HER2-positive (HER2+) breast cancer often develops resistance to therapies like Lapatinib, potentially involving mitochondrial metabolic and redox reprogramming. This study aimed to identify mitochondrial oxidative stress-related genes (MOS-DEGs) as biomarkers of resistance and to characterize their functional nsSNPs and structural impacts. RNA-seq datasets (GSE231524, GSE231525) were analyzed using DESeq2 to identify DEGs, which were intersected with mitochondrial oxidative stress genes to obtain MOS-DEGs. Functional enrichment, PPI analysis, ROC analysis, expression profiling, and survival analysis were performed. nsSNPs were evaluated using multiple predictive tools, and structural impacts were assessed through secondary and 3D modeling. Integrated transcriptomic and clinical analysis identified MTHFD2 and PRDX3 as central MOS-DEGs displaying opposing regulatory roles in mitochondrial redox metabolism. MTHFD2 was significantly upregulated and associated with poor prognosis (HR = 1.53, p = 1.1 × 10⁻16), while PRDX3 exhibited protective expression patterns (HR = 0.73, p = 7.7×10⁻10). ROC analysis suggested their potential as predictors of therapeutic response. nsSNP analysis revealed five deleterious variants in MTHFD2 and four deleterious variants in PRDX3, with rs1471336772 (MTHFD2) and rs747786383 (PRDX3.) identified as the most pathogenic. These variants were predicted to be damaging based on multiple computational scoring systems, including SIFT ≤ 0.05, PolyPhen-2 ≥ 0.85, deleterious CADD scores, and high REVEL scores, and were located within catalytic or redox-active domains. Structural modeling suggested that these substitutions may destabilize conformation, disrupt metal- and cofactor-binding sites, and affect NADPH regeneration or thioredoxin-dependent peroxidase activity. Molecular dynamics predictions indicated potential loss of structural stability and altered flexibility, suggesting possible functional impairment of mitochondrial redox control. This study identifies MTHFD2 and PRDX3 as regulators of mitochondrial oxidative stress in HER2+ breast cancer. Deleterious nsSNPs in these genes may contribute to altered redox balance, potentially influencing metabolic adaptation (MTHFD2) and antioxidant defense (PRDX3).

Subjects

MeSH terms (MEDLINE)

Breast NeoplasmsGene Expression ProfilingHumansFemalePolymorphism, Single NucleotideMethylenetetrahydrofolate Dehydrogenase (NADP)Peroxiredoxin IIIAminohydrolasesMultifunctional EnzymesOxidative Stress

Substances

MTHFD2 protein, humanMethylenetetrahydrofolate Dehydrogenase (NADP)Peroxiredoxin IIIPRDX3 protein, humanAminohydrolasesMultifunctional Enzymes

Authors and institutions

  • Department of Thyroid and Breast Surgery, The Affiliated Hospital of Xuzhou Medical University; x98013112@gmail.com.
  • Department of Anesthesiology, Xuzhou Cancer Hospital.
  • Department of Thyroid and Breast Surgery, The Affiliated Hospital of Xuzhou Medical University.

Cite

APA

Jia, X., Su, H., Zhang, J., & Liu, Z. (2026). Identification of Hub Genes, Single-Nucleotide Polymorphisms, and Potential Drug Targets In Breast Cancer Using Transcriptomic Analysis. Journal of Visualized Experiments. https://doi.org/10.3791/70964

Vancouver

Jia X, Su H, Zhang J, Liu Z. Identification of Hub Genes, Single-Nucleotide Polymorphisms, and Potential Drug Targets In Breast Cancer Using Transcriptomic Analysis. Journal of Visualized Experiments. 2026. doi:10.3791/70964

BibTeX
@article{Jia2026,
  author = {Jia, Xiaobo and Su, Hui and Zhang, Jiaxin and Liu, Zhao},
  title = {Identification of Hub Genes, Single-Nucleotide Polymorphisms, and Potential Drug Targets In Breast Cancer Using Transcriptomic Analysis},
  journal = {Journal of Visualized Experiments},
  year = {2026},
  doi = {10.3791/70964}
}
Start for free →